Skip to content

Admin

Blog Post by Admin

Podcast
Feb 5, 2023

Privacy Tech Talk: May 18, 2022

This podcast on PrivacyTechTalk focuses on synthetic data generation, which is gaining ...
Start Reading
Article
Feb 5, 2023

Real-World Evidence Firm Aetion Grabs Privacy-Protected Synthetic Data Provider Replica Analytics

This article from Fierce Healthcare reports on Aetion's acquisition of Replica Analytics, ...
Start Reading
Article
Feb 5, 2023

Synthetic Data Paradigm for Using and Sharing Data

This article published by Cutter provides an overview of the use cases for synthetic ...
Start Reading
Blog
Feb 3, 2023

A Solution for Payers to Use Real World Evidence in Pharma Confidently

Tackling three common concerns
Start Reading
Presentation
Jan 27, 2023

Changing the Conversation on Privacy – Using Data For Good

Start Reading
Presentation
Jan 18, 2023

Generating and Evaluating Synthetic Clinical Trial Data in a Pharmaceutical Company

Start Reading
Presentation
Jan 18, 2023

A review of the new ISO Standard on Data De-identification: ISO/IEC 27559

Start Reading
Blog
Jan 17, 2023

RWE Meaning | Update: What the Omnibus FDA Amendments Mean for RWE

On December 29, 2022, President Biden signed the Consolidated Appropriations Act, 2023, a ...
Start Reading
Presentation
Dec 1, 2022

Evaluating Privacy Risks in Synthetic Data Using Membership Disclosure

Start Reading
Publication
Nov 1, 2022

Synthetic data as an enabler for machine learning applications in medicine

Start Reading
Blog
Oct 11, 2022

Validating a Membership Disclosure Metric for Synthetic Health Data

By Lucy Mosquera | Posted On: October 11, 2022 We have just had a paper published in ...
Start Reading
Publication
Oct 1, 2022

Validating A Membership Disclosure Metric For Synthetic Health Data

Start Reading
Presentation
Sep 29, 2022

On the Validity of Statistical Analyses with Privacy-Preserving Synthetic Data

Start Reading
Presentation
Sep 13, 2022

Synthetic Data: The Future of Data Sharing?

Start Reading
Blog
Aug 18, 2022

RWE guidance watch: EUnetHTA’s Direct and Indirect Comparisons guidance

The European Network for Health Technology Assessment (EUnetHTA) recently published two ...
Start Reading
Presentation
Jul 21, 2022

Exploring the concept of Identifiability in Canada’s proposed Consumer Privacy Protection Act (Bill C-27)

Khaled El Emam, SVP & GM, Replica Analytics; Adam Kardash, Partner, ...
Start Reading
Blog
Jul 11, 2022

Aetion’s best practices referenced in ENCePP’s updated Guide on Methodological Standards in Pharmacoepidemiology

On July 1, 2022, the European Network of Centres for Pharmacoepidemiology and ...
Start Reading
Blog
Jul 5, 2022

New estimator uses synthetic data generation for more reliable evaluation of re-identification risk in datasets

By Lucy Mosquera and Abhik Das
Start Reading
Presentation
Jun 29, 2022

Assessing Re-identification Risk Using Synthetic Data

Start Reading
Publication
Jun 1, 2022

Measuring re-identification risk using a synthetic estimator to enable data sharing

Start Reading
Presentation
May 25, 2022

Synthetic Data as a Privacy Enhancing Technology

Start Reading
Blog
May 19, 2022

Why work at a startup? Because everything you do matters

Several years ago, during a hiring interview for a software engineer position, the ...
Start Reading
Presentation
May 18, 2022

Generating Synthetic Longitudinal Data

Start Reading
Blog
May 9, 2022

ISPOR Goes Real-World

Regulators, HTAs, and pharma leaders discuss RWE trends with Aetion experts.
Start Reading